Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Markus Posch, Centre For Gene Regulation And Expression, University Of Dundee, UK Image Description: Prometaphase Human Cervical Carcinoma (HeLa) Cell With GFP-histone Labeled Chromosomes (blue) Stained For Tubulin (yellow). Disease Focus: Cancer (Photo: Business Wire)

Stock quotes in this article: GE 

GE Healthcare Life Sciences today announced Jane Stout, from the United States, Anushree Balachandran from Australia and Markus Posch from the UK as the winners of the GE Healthcare 2012 Cell Imaging Competition. With over 15,000 votes cast in a public vote, the winners can now look forward to seeing their prize-winning cellular images displayed in Times Square, New York on NBC Universal’s HD screen at a special event on April 19-21, 2013.

Jane Stout, School of Medicine, Indiana University, Bloomington, USA Image Description: Metaphase ep ...

Jane Stout, School of Medicine, Indiana University, Bloomington, USA Image Description: Metaphase epithelial cell stained for microtubules (red), kinetochores (green) and DNA (blue). Disease focus: Cancer (Photo: Business Wire)

Now in its sixth year, GE Healthcare’s annual competition showcases the beauty of cells and the inspiring research conducted by cellular biologists around the world. In 2012, for the first time, there were two categories for submission; High-Content Analysis and Microscopy. The competition attracted over 100 entries from researchers who are investigating at the cellular level conditions such as cancer, HIV, and neurodegenerative disease. An expert scientific panel of five judges* shortlisted the finalists for each category, which then went forward to the public vote.

The full details of the three winners are:

1 st place - Microscopy category

Jane Stout, School of Medicine, Indiana University, Bloomington, USADisease focus: Cancer

1 st place – High-Content Analysis category

Anushree Balachandran, Genea, Sydney, AustraliaDisease focus: Huntingdon’s disease

Regional winner - Microscopy category

Markus Posch, Centre for Gene Regulation and Expression, University of Dundee, UKDisease focus: Cancer

Eric Roman, General Manager of Research and Applied Markets, GE Healthcare Life Sciences, said: “This year’s winning images are as beautiful and compelling as ever. Not only can they be appreciated from an aesthetic point of view, but they remind us of the cellular complexity behind disease and why the study of cells is so important. We were delighted to receive so many outstanding entries to the competition, which highlights how high-content and super-resolution cell imaging are helping scientists explore the universe of the cell, and so advance our understanding of so many life threatening and life-limiting diseases. We thank all the contestants for sending us their images, the judging panel and everyone who cast a vote.”

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs